Healthpeak Properties, Inc. PEAK
We take great care to ensure that the data presented and summarized in this overview for HEALTHPEAK PROPERTIES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PEAK
View all-
Vanguard Group Inc Valley Forge, PA109MShares$2.07 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY77MShares$1.46 Billion0.03% of portfolio
-
State Street Corp Boston, MA49.5MShares$939 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY28.2MShares$536 Million0.04% of portfolio
-
Principal Financial Group Inc Des Moines, IA27MShares$512 Million0.28% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA24.9MShares$472 Million1.65% of portfolio
-
Geode Capital Management, LLC Boston, MA19.4MShares$368 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA16.7MShares$316 Million0.05% of portfolio
-
Centersquare Investment Management LLC Plymouth Meeting, PA14.1MShares$268 Million2.78% of portfolio
-
Morgan Stanley New York, NY12.2MShares$231 Million0.01% of portfolio
Latest Institutional Activity in PEAK
Top Purchases
Top Sells
About PEAK
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
Insider Transactions at PEAK
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 28
2025
|
John T Thomas Director |
SELL
Payment of exercise price or tax liability
|
Direct |
81
-0.01%
|
$1,458
$18.26 P/Share
|
|
Nov 28
2025
|
John T Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,448
+0.18%
|
$20,272
$14.8 P/Share
|
|
Nov 28
2025
|
Kelvin O Moses Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55
-6.79%
|
$990
$18.26 P/Share
|
|
Nov 28
2025
|
Kelvin O Moses Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
810
+50.0%
|
$11,340
$14.8 P/Share
|
|
Nov 28
2025
|
Adam G Mabry CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
58
-1.27%
|
$1,044
$18.26 P/Share
|
|
Nov 28
2025
|
Adam G Mabry CIO |
BUY
Grant, award, or other acquisition
|
Direct |
844
+15.58%
|
$11,816
$14.8 P/Share
|
|
Nov 28
2025
|
Ankit B. Patadia EVP and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-1.47%
|
$2,070
$18.26 P/Share
|
|
Nov 28
2025
|
Ankit B. Patadia EVP and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
1,689
+17.79%
|
$23,646
$14.8 P/Share
|
|
Nov 28
2025
|
Shawn G Johnston EVP and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.22%
|
$1,656
$18.26 P/Share
|
|
Nov 28
2025
|
Shawn G Johnston EVP and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,689
+3.95%
|
$23,646
$14.8 P/Share
|
|
Nov 28
2025
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23
-0.11%
|
$414
$18.26 P/Share
|
|
Nov 28
2025
|
Lisa A Alonso EVP and Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338
+1.64%
|
$4,732
$14.8 P/Share
|
|
Nov 28
2025
|
Scott M Brinker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
140
-0.07%
|
$2,520
$18.26 P/Share
|
|
Nov 28
2025
|
Scott M Brinker President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,689
+0.78%
|
$23,646
$14.8 P/Share
|
|
Aug 06
2025
|
John T Thomas Director |
BUY
Open market or private purchase
|
Direct |
1,450
+0.18%
|
$24,650
$17.05 P/Share
|
|
Aug 04
2025
|
Scott M Brinker President and CEO |
BUY
Open market or private purchase
|
Direct |
1,490
+0.7%
|
$23,840
$16.83 P/Share
|
|
Jul 31
2025
|
Scott M Brinker President and CEO |
BUY
Open market or private purchase
|
Direct |
2,930
+1.37%
|
$49,810
$17.06 P/Share
|
|
Jul 28
2025
|
John T Thomas Director |
SELL
Bona fide gift
|
Direct |
5,000
-0.61%
|
-
|
|
Jul 28
2025
|
Scott M Brinker President and CEO |
BUY
Open market or private purchase
|
Direct |
2,873
+1.37%
|
$48,841
$17.4 P/Share
|
|
May 28
2025
|
Tommy G Thompson Director |
BUY
Open market or private purchase
|
Direct |
5,777
+3.85%
|
$98,209
$17.27 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 132K shares |
|---|---|
| Open market or private purchase | 63.6K shares |
| Payment of exercise price or tax liability | 15.9K shares |
|---|---|
| Bona fide gift | 53.8K shares |